华平信息技术股份有限公司 公告 证券代码：300074 证券简称：华平股份 编号：202507-032 华平信息技术股份有限公司 第六届董事会第二次（临时）会议决议公告 本公司及其董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 华平信息技术股份有限公司（下称"公司"）第六届董事会第二次（临时） 会议于 2025 年 7 月 31 日 14:30 在上海市杨浦区国权北路 1688 号湾谷科技园 A6 栋公司会议室以现场方式和通讯方式召开。本次会议应参加董事 9 人，实际出席 董事 9 人，公司全体监事、高级管理人员列席了此次会议。本次董事会通知已于 2025 年 7 月 25 日通过邮件发送至全体董事、监事。本次董事会会议的召集、召 开符合《公司法》和《公司章程》的有关规定。此次会议由董事长蒋孟衡先生主 持，与会董事认真审议，形成如下决议： 一、审议通过《关于增加公司经营范围及修订<公司章程>的议案》 为全面贯彻落实最新法律法规和监管规定要求，进一步规范公司运作机制， 持续提升公司治理水平，根据《公司法》《上市公司章程指引》《深圳证券交易 所创业板股票上市规则》《深圳证券交易 ...

通过天眼查大数据分析，华平信息技术股份有限公司共对外投资了15家企业，参与招投标项目1078次， 知识产权方面有商标信息28条，专利信息187条，此外企业还拥有行政许可13个。 来源：金融界 华平股份最新一期业绩显示，截至2025一季报，公司营业总收入7126.70万元、同比增长99.07%，归属 净利润1698.24万元，同比增长43.81%，扣非净利润1746.25万元，同比增长45.71%，流动比率2.430、速 动比率2.079、资产负债率34.74%。 天眼查商业履历信息显示，华平信息技术股份有限公司，成立于2003年，位于上海市，是一家以从事软 件和信息技术服务业为主的企业。企业注册资本53102.09万人民币，实缴资本3000万人民币。公司法定 代表人为蒋孟衡。 金融界消息 截至2025年7月30日收盘，华平股份（300074）报收于5.08元，下跌1.36%，换手率3.33%， 成交量18.04万手，成交金额9139.72万元。 资金流向方面，今日主力资金净流出1514.30万元，占比成交额16.57%。其中，超大单净流出911.43万 元、占成交额9.97%，大单净流出602.87万元、占成 ...

证券日报网讯华平股份（300074）7月30日在互动平台回答投资者提问时表示，公司仍在积极推进低空 经济相关业务布局，核心抓手是自主研发的"无人机综合业务管理平台"。该平台以应急指挥调度与无人 机应用管理一体化为设计思路，已具备模块化、可快速部署能力，可广泛服务于消防巡检、城市安防、 应急救援等场景。业绩情况请以公司披露的定期报告为准，公司将继续无人机平台研发及行业示范应用 的投入，力争抓住低空经济政策窗口。 ...

公司回答表示：尊敬的投资者，您好！公司仍在积极推进低空经济相关业务布局，核心抓手是自主研发 的"无人机综合业务管理平台"。该平台以应急指挥调度与无人机应用管理一体化为设计思路，已具备模 块化、可快速部署能力，可广泛服务于消防巡检、城市安防、应急救援等场景。业绩情况请以公司披露 的定期报告为准，公司将继续无人机平台研发及行业示范应用的投入，力争抓住低空经济政策窗口，感 谢您的关注！ 金融界7月30日消息，有投资者在互动平台向华平股份提问：公司是否还在布局低空经济市场，近半年 这方面业绩如何。 来源：金融界 ...

Core Insights - The Internet of Things (IoT) is transitioning from concept to a central industry component, with Shenzhen positioning itself as a "speed pioneer city" in this domain [2][5] - Leading companies in Longgang are leveraging technology to reshape the IoT ecosystem, contributing to the global digital wave [2][5] Group 1: Company Innovations - Shenzhen Macro Electric Technology Co., Ltd. has developed proprietary E-Link and A-Link protocols to efficiently manage data from various sensors, aiding municipal monitoring [3] - Huaping Information Technology Co., Ltd. focuses on visual communication and image intelligence, creating a "smart property management platform" that visualizes operational dynamics [3] - Shenzhen Today International Logistics Technology Co., Ltd. has an industrial IoT platform that connects thousands of devices, supporting automated warehouse management for major factories [3] Group 2: Practical Applications - Macro Electric provides customized solutions across various sectors, including water management and emergency response systems, showcasing its ability to create reusable digital components [4] - Huaping's technology has been instrumental in disaster response, integrating drone footage and monitoring data to create precise situational maps [4] - Today International's platform supports intelligent logistics, having implemented over a thousand projects across various industries [4] Group 3: Future Outlook - The IoT is seen as the third wave of the information industry, with significant potential to enhance efficiency in agriculture and manufacturing [5] - Shenzhen is home to over 70% of China's IoT industry chain, with Longgang aiming to become a new high ground for IoT applications [5] - The "Shenzhen Longgang District Action Plan for Creating an AI Application Demonstration Zone (2024-2025)" encourages the adoption of IoT technologies to accelerate innovation [5]

华平信息技术股份有限公司 公告 证券代码：300074 证券简称：华平股份 公告编号：202505-031 华平信息技术股份有限公司 2024 年年度股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会无增加、变更提案的情况； 2、本次股东会共审议7项议案，该7项议案均获得股东会审议通过； 3、本次股东会以现场投票和网络投票相结合的方式召开； 4、本次股东会没有涉及变更以往股东会已通过的决议。 一、会议召开情况 华平信息技术股份有限公司（以下简称"公司"）2024年年度股东会采取现 场投票和网络投票相结合的方式召开，其中现场会议召开时间为2025年5月23日 14:30，召开地点为上海市杨浦区国权北路1688号湾谷科技园A6栋会议室；通过 深圳证券交易所交易系统进行网络投票的具体时间为2025年5月23日上午 9:15-9:25，9:30-11:30和下午13:00-15:00；通过深圳证券交易所互联网系统投 票的具体时间为2025年5月23日9:15至15:00的任意时间。 本次会议由公司董事会召集，公司董事长蒋孟衡先生 ...

德恒上海律师事务所 关于 华平信息技术股份有限公司 2024年年度股东会之 见证法律意见书 中国上海市虹口区东大名路 501 号上海白玉兰广场办公楼 23 层 200080 Floor23，Sinar Mas Plaza，No.501EastDaMingRoad，Shanghai 电话（Tel）：86-21-55989888 传真（Fax）：86-21-55989898 网址（Website）：www.dehenglaw.com 德恒上海律师事务所 德恒上海律师事务所（以下简称"本所"）接受华平信息技术股份有限公司 （以下简称"公司"）的委托，指派本所承办律师列席公司于 2025 年 5 月 23 日 下午14:30在上海市杨浦区国权北路1688号湾谷科技园A6栋会议室召开的2024 年年度股东会（以下简称"本次股东会"），就本次股东会的召集、召开程序、 现场出席会议人员资格、表决程序等相关事项进行见证，并出具本法律意见。 本所承办律师依据本法律意见出具日前已经发生或存在的事实和《中华人民 共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公司法》（以 下简称"《公司法》"）、《上市公司股东会规则》（ ...

Group 1 - The DRG/DIP concept declined by 3.30%, ranking among the top declines in the concept sector, with notable declines in companies such as Chuangying Huikang, ST Yilianzhong, and Jiahe Meikang [1][2] - The DRG/DIP concept experienced a net outflow of 4.92 billion yuan in main funds, with 19 stocks seeing net outflows, and 13 stocks with outflows exceeding 10 million yuan [2] - The stock with the highest net outflow was Donghua Software, with a net outflow of 1.26 billion yuan, followed by Chuangying Huikang, Weining Health, and Dian Diagnosis [2][3] Group 2 - The top stocks with net outflows in the DRG/DIP concept included Donghua Software (-3.97%), Chuangying Huikang (-6.76%), and Weining Health (-4.60%) [2][3] - Conversely, the stocks with net inflows included Huaping Co., Guoke Hengtai, and Wanda Information, with net inflows of 238.84 million yuan, 166.15 million yuan, and 121.00 million yuan respectively [2]

Group 1: Company Performance and Financials - The company reported a cautious approach to asset impairment testing due to macroeconomic uncertainties, leading to increased expenses and losses despite government subsidies received in the previous year [3][4]. - The company has a robust cash flow situation, with sufficient working capital, and is applying for credit lines from banks to optimize cash assets [3][4]. - The company aims to enhance profitability through increased R&D investment in advanced technologies and high-value products, while also optimizing production processes and supply chain management [3][4]. Group 2: Strategic Planning and Market Position - The company has established a clear three-pronged strategic plan focusing on business, financial, and product innovation goals, leveraging its core competencies in the video conferencing sector [6][12]. - The new management team is committed to developing strategies based on external market conditions and internal capabilities, with a focus on enhancing profitability and shareholder returns [7][12]. - The company is actively evaluating its asset structure and will continue to assess the strategic alignment and investment returns of its assets [4][6]. Group 3: Investor Relations and Communication - The company has implemented a market value management system to improve communication and management practices, aiming to reflect its investment value accurately [4][15]. - The company has conducted an online earnings briefing to engage with investors and address their inquiries regarding performance and future strategies [2][3]. - The company has committed to timely disclosures regarding stock repurchase plans and other significant corporate actions [14][15]. Group 4: Industry Trends and Future Outlook - The company is exploring new market demands and applications for its command and dispatch systems, indicating a proactive approach to market expansion [10][12]. - The company is focusing on the development of AI-driven products in the healthcare sector through its subsidiary, aiming to enhance operational efficiency and user responsiveness [16][19]. - The company is considering investments in low-altitude economy projects and has previously collaborated with DJI in related fields [17][19].

Core Viewpoint - The implementation of the "Pharmaceutical Industry Digital Transformation Implementation Plan (2025-2030)" by seven government departments aims to enhance the digital transformation across the entire pharmaceutical industry chain, focusing on the deep application of artificial intelligence technology and the cultivation of excellent enterprises [1][3]. Group 1: Market Impact - Following the announcement, the pharmaceutical digitalization sector in the A-share market saw a collective rise, with notable increases such as 13.16% for Sichuang Medical [2][1]. - The digital transformation plan is expected to create significant opportunities for the pharmaceutical industry, effectively equipping it with a "digital brain" to enhance efficiency and reduce costs [6][7]. Group 2: Development Goals - The plan outlines two key stages: by 2027, significant progress in digital transformation should be achieved, and by 2030, large-scale pharmaceutical enterprises should have fully realized digital transformation [3][4]. - Specific targets include the development of over 30 digital technology standards and the establishment of more than 100 exemplary application scenarios in the pharmaceutical industry [4][5]. Group 3: Key Tasks - The plan identifies four major tasks: empowering with digital technology, promoting digital transformation, building a digital service system, and enhancing digital regulation [5][6]. Group 4: Market Growth Potential - The digital healthcare market in China is projected to exceed 1.2 trillion yuan by the end of 2024, with a compound annual growth rate of 24.5% [8]. - By 2025, the digital healthcare market is expected to surpass 1.8 trillion yuan, and by 2030, it could reach 2.5 trillion yuan, indicating a significant market opportunity driven by policy, technology, and demand [9]. Group 5: Company Innovations - Companies like Hengrui Medicine and Fosun Pharma are collaborating with AI platforms to enhance the efficiency of innovative drug development [11]. - Other firms, such as WuXi AppTec and Chengdu XianDao, are integrating AI into their research processes to improve precision and efficiency in drug development [10][11].